Arthritis & Rheumatology · 2013 · 73 citations · 39 references
These results show that ERAP1 directly alters peptide binding and presentation by HLA-B27, thus demonstrating a potential pathogenic mechanism in AS. Inhibition of ERAP1 could potentially be used for treatment of AS and other ERAP1-associated diseases.
39
David M. Evans, Chris C. A. Spencer, Jennifer J. Pointon et al. · Nature Genetics · 2011 · 887 citations · Full text
Identification of self peptides bound to purified HLA-B27
Theodore S. Jardetzky, W S Lane, Ruth A. Robinson et al. · Nature · 1991 · 831 citations